-
1
-
-
84873638532
-
Aging, cellular senescence, and cancer
-
Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685-705.
-
(2013)
Annu Rev Physiol
, vol.75
, pp. 685-705
-
-
Campisi, J.1
-
2
-
-
84949555897
-
Cellular senescence in aging and age-related disease: From mechanisms to therapy
-
Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 2015; 21: 1424-35.
-
(2015)
Nat Med
, vol.21
, pp. 1424-1435
-
-
Childs, B.G.1
Durik, M.2
Baker, D.J.3
Van Deursen, J.M.4
-
3
-
-
80855138775
-
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
-
Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-6.
-
(2011)
Nature
, vol.479
, pp. 232-236
-
-
Baker, D.J.1
Wijshake, T.2
Tchkonia, T.3
Lebrasseur, N.K.4
Childs, B.G.5
Van De Sluis, B.6
-
4
-
-
84958093401
-
Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan
-
Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 2016; 530: 184-9.
-
(2016)
Nature
, vol.530
, pp. 184-189
-
-
Baker, D.J.1
Childs, B.G.2
Durik, M.3
Wijers, M.E.4
Sieben, C.J.5
Zhong, J.6
-
5
-
-
84891713034
-
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor
-
Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853-68.
-
(2008)
Plos Biol
, vol.6
, pp. 2853-2868
-
-
Coppe, J.P.1
Patil, C.K.2
Rodier, F.3
Sun, Y.4
Munoz, D.P.5
Goldstein, J.6
-
6
-
-
53949121846
-
Systemic cancer therapy: Evolution over the last 60 years
-
Dy GK, Adjei AA. Systemic cancer therapy: evolution over the last 60 years. Cancer 2008; 113: 1857-87.
-
(2008)
Cancer
, vol.113
, pp. 1857-1887
-
-
Dy, G.K.1
Adjei, A.A.2
-
7
-
-
55549110370
-
Cancer fatigue syndrome reflects clinically non-overt heart failure: An approach towards oncocardiology
-
Schunemann M, Anker SD, Rauchhaus M. Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards oncocardiology. Nat Clin Pract Oncol 2008; 5: 632-3.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 632-633
-
-
Schunemann, M.1
Anker, S.D.2
Rauchhaus, M.3
-
8
-
-
84878854824
-
Clinical ascertainment of health outcomes among adults treated for childhood cancer
-
Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013; 309: 2371-81.
-
(2013)
JAMA
, vol.309
, pp. 2371-2381
-
-
Hudson, M.M.1
Ness, K.K.2
Gurney, J.G.3
Mulrooney, D.A.4
Chemaitilly, W.5
Krull, K.R.6
-
9
-
-
0038013875
-
Senescence, apoptosis and therapy-cutting the lifelines of cancer
-
Schmitt CA. Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nat Rev Cancer 2003; 3: 286-95.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 286-295
-
-
Schmitt, C.A.1
-
10
-
-
84868633053
-
Treatmentinduced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
-
Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, et al. Treatmentinduced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 2012; 18: 1359-68.
-
(2012)
Nat Med
, vol.18
, pp. 1359-1368
-
-
Sun, Y.1
Campisi, J.2
Higano, C.3
Beer, T.M.4
Porter, P.5
Coleman, I.6
-
12
-
-
84898927522
-
Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer
-
Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, et al. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst 2014; 106: dju057.
-
(2014)
J Natl Cancer Inst
, vol.106
-
-
Sanoff, H.K.1
Deal, A.M.2
Krishnamurthy, J.3
Torrice, C.4
Dillon, P.5
Sorrentino, J.6
-
13
-
-
33748327046
-
P16INK4A is a robust in vivo biomarker of cellular aging in human skin
-
Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, Jansen-Durr P, et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006; 5: 379-89.
-
(2006)
Aging Cell
, vol.5
, pp. 379-389
-
-
Ressler, S.1
Bartkova, J.2
Niederegger, H.3
Bartek, J.4
Scharffetter-Kochanek, K.5
Jansen-Durr, P.6
-
14
-
-
84900969225
-
Ink4a/Arf expression is a biomarker of aging
-
Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114: 1299-307.
-
(2004)
J Clin Invest
, vol.114
, pp. 1299-1307
-
-
Krishnamurthy, J.1
Torrice, C.2
Ramsey, M.R.3
Kovalev, G.I.4
Al-Regaiey, K.5
Su, L.6
-
15
-
-
84919480323
-
An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA
-
Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 2014; 31: 722-33.
-
(2014)
Dev Cell
, vol.31
, pp. 722-733
-
-
Demaria, M.1
Ohtani, N.2
Youssef, S.A.3
Rodier, F.4
Toussaint, W.5
Mitchell, J.R.6
-
16
-
-
77954187741
-
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
-
Pommier Y, Leo E, Zhang H, Marchand C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 2010; 17: 421-33.
-
(2010)
Chem Biol
, vol.17
, pp. 421-433
-
-
Pommier, Y.1
Leo, E.2
Zhang, H.3
Marchand, C.4
-
17
-
-
84878732407
-
Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
-
Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, et al. Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat Commun 2013; 4: 1908.
-
(2013)
Nat Commun
, vol.4
, pp. 1908
-
-
Pang, B.1
Qiao, X.2
Janssen, L.3
Velds, A.4
Groothuis, T.5
Kerkhoven, R.6
-
19
-
-
84878619211
-
P53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
-
Davalos AR, Kawahara M, Malhotra GK, Schaum N, Huang J, Ved U, et al. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol 2013; 201: 613-29.
-
(2013)
J Cell Biol
, vol.201
, pp. 613-629
-
-
Davalos, A.R.1
Kawahara, M.2
Malhotra, G.K.3
Schaum, N.4
Huang, J.5
Ved, U.6
-
20
-
-
68249096784
-
Ersistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
-
Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, Munoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11: 973-9.
-
(2009)
Nat Cell Biol
, vol.11
, pp. 973-979
-
-
Rodier, F.1
Coppe, J.P.2
Patil, C.K.3
Hoeijmakers, W.A.4
Munoz, D.P.5
Raza, S.R.6
-
21
-
-
37349062063
-
Decoding dangerous death: How cytotoxic chemotherapy invokes inflammation, immunity or nothing at all
-
van der Most RG, Currie AJ, Robinson BW, Lake RA. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all. Cell Death Differ 2008; 15: 13-20.
-
(2008)
Cell Death Differ
, vol.15
, pp. 13-20
-
-
Van Der Most, R.G.1
Currie, A.J.2
Robinson, B.W.3
Lake, R.A.4
-
22
-
-
0032563825
-
Doxorubicin-induced cardiomyopathy
-
Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900-5.
-
(1998)
N Engl J Med
, vol.339
, pp. 900-905
-
-
Singal, P.K.1
Iliskovic, N.2
-
24
-
-
84954218515
-
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
-
Chang J, Wang Y, Shao L, Laberge RM, Demaria M, Campisi J, et al. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med 2016; 22: 78-83.
-
(2016)
Nat Med
, vol.22
, pp. 78-83
-
-
Chang, J.1
Wang, Y.2
Shao, L.3
Laberge, R.M.4
Demaria, M.5
Campisi, J.6
-
25
-
-
84992424395
-
Cancer-related fatigue in patients with and survivors of Hodgkin’s lymphoma: A longitudinal study of the German Hodgkin Study Group
-
Kreissl S, Mueller H, Goergen H, Mayer A, Brillant C, Behringer K, et al. Cancer-related fatigue in patients with and survivors of Hodgkin’s lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol 2016; 17: 1453-62.
-
(2016)
Lancet Oncol
, vol.17
, pp. 1453-1462
-
-
Kreissl, S.1
Mueller, H.2
Goergen, H.3
Mayer, A.4
Brillant, C.5
Behringer, K.6
-
26
-
-
67651180787
-
Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging
-
Liu Y, SanoffHK, Cho H, Burd CE, Torrice C, Ibrahim JG, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell 2009; 8: 439-48.
-
(2009)
Aging Cell
, vol.8
, pp. 439-448
-
-
Liu, Y.1
Sanoff, H.K.2
Cho, H.3
Burd, C.E.4
Torrice, C.5
Ibrahim, J.G.6
-
27
-
-
84994893941
-
Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging
-
Wood WA, Krishnamurthy J, Mitin N, Torrice C, Parker JS, Snavely AC, et al. Chemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging. EBioMedicine 2016; 11: 227-38.
-
(2016)
Ebiomedicine
, vol.11
, pp. 227-238
-
-
Wood, W.A.1
Krishnamurthy, J.2
Mitin, N.3
Torrice, C.4
Parker, J.S.5
Snavely, A.C.6
-
28
-
-
84872569990
-
Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model
-
Burd CE, Sorrentino JA, Clark KS, Darr DB, Krishnamurthy J, Deal AM, et al. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 2013; 152: 340-51.
-
(2013)
Cell
, vol.152
, pp. 340-351
-
-
Burd, C.E.1
Sorrentino, J.A.2
Clark, K.S.3
Darr, D.B.4
Krishnamurthy, J.5
Deal, A.M.6
-
29
-
-
84931031396
-
Cell autonomous and non-autonomous effects of senescent cells in the skin
-
Demaria M, Desprez PY, Campisi J, Velarde MC. Cell autonomous and non-autonomous effects of senescent cells in the skin. J Invest Dermatol 2015; 135: 1722-6.
-
(2015)
J Invest Dermatol
, vol.135
, pp. 1722-1726
-
-
Demaria, M.1
Desprez, P.Y.2
Campisi, J.3
Velarde, M.C.4
-
30
-
-
84884417141
-
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
-
Dorr JR, Yu Y, Milanovic M, Beuster G, Zasada C, Dabritz JH, et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013; 501: 421-5.
-
(2013)
Nature
, vol.501
, pp. 421-425
-
-
Dorr, J.R.1
Yu, Y.2
Milanovic, M.3
Beuster, G.4
Zasada, C.5
Dabritz, J.H.6
-
31
-
-
18044385339
-
Telomere dynamics in response to chemotherapy
-
Beeharry N, Broccoli D. Telomere dynamics in response to chemotherapy. Curr Mol Med 2005; 5: 187-96.
-
(2005)
Curr Mol Med
, vol.5
, pp. 187-196
-
-
Beeharry, N.1
Broccoli, D.2
-
32
-
-
84938751873
-
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
-
Laberge RM, Sun Y, Orjalo AV, Patil CK, Freund A, Zhou L, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 2015; 17: 1049-61.
-
(2015)
Nat Cell Biol
, vol.17
, pp. 1049-1061
-
-
Laberge, R.M.1
Sun, Y.2
Orjalo, A.V.3
Patil, C.K.4
Freund, A.5
Zhou, L.6
-
33
-
-
84883785478
-
Late-life rapamycin treatment reverses age-related heart dysfunction
-
Flynn JM, O’Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 2013; 12: 851-62.
-
(2013)
Aging Cell
, vol.12
, pp. 851-862
-
-
Flynn, J.M.1
O’Leary, M.N.2
Zambataro, C.A.3
Academia, E.C.4
Presley, M.P.5
Garrett, B.J.6
|